China Shineway Pharmaceutical Group Limited
0.78
EUR
-0.10
(-11.93%)
Important Dates
China Shineway Pharmaceutical Group Limited's next confirmed earnings release is scheduled for March 30, 2027.
| Earnings Date | 3/30/2027 |
Share Statistics
As of December 31, 2025, China Shineway Pharmaceutical Group Limited has 755.40M shares outstanding.
| Shares Outstanding | 755.40M |
Financial Position
As of December 31, 2025, China Shineway Pharmaceutical Group Limited maintains a current ratio of 3.71, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.71 |
| Quick Ratio | 3.01 |
| Debt / Equity | 4.15 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 3,021.00 |
Balance Sheet
EURAs of December 31, 2025, China Shineway Pharmaceutical Group Limited holds 920.85M in cash and equivalents against 40.76M in total debt, resulting in a net debt position of -835.45M. Total book value stands at 981.24M, with working capital of 826.92M providing operational flexibility.
| Cash & Cash Equivalents | 920.85M |
| Total Debt | 40.76M |
| Net Debt | -835.45M |
| Equity (Book Value) | 981.24M |
| Book Value Per Share | 1.30 |
| Working Capital | 826.92M |